Ezra M. Greenspan, MD, Professor in Clinical Cancer Therapeutics
Chief, Division of Hematology/Oncology, Icahn School of Medicine at Mt. Sinai
Deputy Director, Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
For illuminating clinical cancer research dedicated to improving therapeutic options for the treatment of breast cancer and HIV-associated cancers. Dr. Sparano led the landmark TAILORx clinical trial that transformed the standard of care for women with early-stage ER-Positive, HER-2 Negative, node negative breast cancer, resulting in chemotherapy usage guided by the 21-gene Oncotype DX recurrence score and sparing patients from unnecessary chemotherapy regimens. Further, Dr. Sparano is recognized for characterizing factors that contribute to racial disparities in breast cancer and for establishing improved clinical treatment and surveillance protocols for black breast cancer patients.
The AACR and Bristol-Myers Squibb established this award in 1996 to recognize outstanding achievements in clinical cancer research. The award honors Dr. Joseph H. Burchenal, honorary member and past president of the AACR, and a major figure in clinical cancer research. To learn more, please visit the press release.
View Past Recipients.